Ovid Therapeutics Inc. (OVID) Operating income 2016–2025
Ovid Therapeutics Inc. (OVID) annual operating income history from SEC filings — each fiscal year as reported.
-$42.4MFY2025 · since FY2016: -$22.5M → -$42.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$42.4M | +31.4% |
| FY2024 | -$61.9M | -4.4% |
| FY2023 | -$59.3M | -6.7% |
| FY2022 | -$55.5M | -144.7% |
| FY2021 | $124.2M | +252.5% |
| FY2020 | -$81.4M | -32.6% |
| FY2019 | -$61.4M | -16.0% |
| FY2018 | -$52.9M | +18.6% |
| FY2017 | -$65.0M | -188.5% |
| FY2016 | -$22.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice